Drug Database
Back to search

Netherlands· NL-dcd3634dee03

Tirofiban Eugia 0,05 mg/ml, oplossing voor infusie

A tirofiban product containing tirofibanhydrochloride 1-water, registered in Netherlands by Eugia Pharma (Malta) Limited. The same ATC class is registered in 11 of our 19 countries.

ATC B01AC17

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTirofiban Eugia 0,05 mg/ml, oplossing…ATCB01AC17REGISTER NO.NL-dcd3634dee03PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tirofibanhydrochloride 1-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tirofiban is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AC17 (tirofiban), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search tirofiban products by name

Tirofiban · ATC B01AC17

11 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TIROFIBANHYDROCHLORIDE 1-WATER
Manufacturer
Eugia Pharma (Malta) Limited
Country
Netherlands (NL)
ATC code
B01AC17
ATC class
Tirofiban
Defined daily dose
10 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    132381

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

159 interactions on record for tirofiban.

Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tirofiban against other medicinesHow interaction checks work

Tirofiban · interactions on record

159 records

  • 62 severe
  • 75 moderate
  • 22 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • DalteparinB01AB04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tirofiban in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tirofiban products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Austria · Aggrastat
  • Belgium · Aggrastat
  • Bulgaria · Аграстат, Тирофибан Чайкафарма
  • Cyprus · Aggrastat, Αggrafiban
  • Germany · Aggrastat, Tirofiban Ibisqus
  • Estonia · Aggrastat
  • Spain · Agrastat, Tirofiban Altan Pharmaceuticals S.A.
  • Finland · Aggrastat
  • France · Agrastat, Tirofiban Altan
  • United Kingdom (Northern Ireland) · Aggrastat, Tirofiban Eugia (Uk)
  • Greece · Aggrastat, Αggrafiban
  • Hungary · Aggrastat
  • Italy · Aggrastat, Tirofiban Aurobindo
  • Lithuania · Aggrastat
  • Luxembourg · Aggrastat
  • Latvia · Aggrastat
  • Malta · Aggrastat, Tirofiban Ibigen
  • Portugal · Tirofibano, Tirofibano Generis
  • Sweden · Aggrastat

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/657d328e-5064-405b-ad51-0180a4c322fc
GET /v1/drugs/657d328e-5064-405b-ad51-0180a4c322fc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132381_smpc_en.pdf",
  "strength": null,
  "atc_label": "Tirofiban",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132381",
  "excipients": [
    "CITROENZUUR 0-WATER (E 330)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "TIROFIBANHYDROCHLORIDE 1-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132381_piluk.pdf",
  "authorised_at": "2025/02/26",
  "procedure_number": "PT/H/2584/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132381",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tirofiban.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console